05/02/2025
11:33 AM | BioMarin Pharmaceutical (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/02/2025
9:05 AM | BioMarin Pharmaceutical (Subject)
Hubbard Cristin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/29/2025
8:14 AM | BioMarin Pharmaceutical (Subject)
BlackRock, Inc. (Filed by)
| Form SCHEDULE 13G/A | |
04/08/2025
3:09 PM | BioMarin Pharmaceutical (Filer)
| Form DEF 14A | |
04/08/2025
3:12 PM | BioMarin Pharmaceutical (Filer)
| Form DEFA14A | |
03/20/2025
6:38 PM | BioMarin Pharmaceutical (Issuer)
Burkhart Erin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2025
8:36 AM | BioMarin Pharmaceutical (Subject)
Burkhart Erin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/18/2025
6:51 PM | BioMarin Pharmaceutical (Issuer)
Davis George Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2025
6:53 PM | BioMarin Pharmaceutical (Issuer)
Burkhart Erin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2025
5:23 PM | BioMarin Pharmaceutical (Issuer)
Friberg Gregory R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2025
5:25 PM | BioMarin Pharmaceutical (Issuer)
Hubbard Cristin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for BMRN and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for BioMarin Pharmaceutical and its competitors with MarketBeat's FREE daily newsletter. |
03/18/2025
5:17 PM | BioMarin Pharmaceutical (Issuer)
Hardy Alexander (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2025
5:19 PM | BioMarin Pharmaceutical (Issuer)
Mueller Brian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2025
5:22 PM | BioMarin Pharmaceutical (Issuer)
Guyer Charles Greg (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
3:11 PM | BioMarin Pharmaceutical (Issuer)
Guyer Charles Greg (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2025
6:15 PM | BioMarin Pharmaceutical (Issuer)
Davis George Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2025
6:17 PM | BioMarin Pharmaceutical (Issuer)
Guyer Charles Greg (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2025
6:19 PM | BioMarin Pharmaceutical (Issuer)
Mueller Brian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/26/2025
3:18 PM | BioMarin Pharmaceutical (Issuer)
Walbert Timothy P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/25/2025
7:21 PM | BioMarin Pharmaceutical (Issuer)
Burkhart Erin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/24/2025
12:54 PM | BioMarin Pharmaceutical (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/24/2025
9:26 AM | BioMarin Pharmaceutical (Subject)
Burkhart Erin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/19/2025
3:07 PM | BioMarin Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/13/2025
1:14 PM | BioMarin Pharmaceutical (Subject)
Capital Research Global Investors (Filed by)
| Form SCHEDULE 13G/A | |
12/03/2024
5:15 PM | BioMarin Pharmaceutical (Issuer)
Hardy Alexander (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2024
1:44 PM | BioMarin Pharmaceutical (Issuer)
Guyer Charles Greg (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/12/2024
1:27 PM | BioMarin Pharmaceutical (Subject)
Guyer Charles Greg (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/31/2024
2:01 PM | BioMarin Pharmaceutical (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/01/2024
3:50 PM | BioMarin Pharmaceutical (Issuer)
Friberg Gregory R (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/01/2024
3:51 PM | BioMarin Pharmaceutical (Issuer)
Friberg Gregory R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/30/2024
3:29 PM | BioMarin Pharmaceutical (Subject)
VIKING GLOBAL INVESTORS LP (Filed by)
| Form SC 13G | |
09/24/2024
7:31 AM | BioMarin Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/17/2024
4:54 PM | BioMarin Pharmaceutical (Issuer)
FUCHS HENRY J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
11:52 AM | BioMarin Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/28/2024
4:02 PM | BioMarin Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/22/2024
4:00 PM | BioMarin Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/13/2024
10:48 AM | BioMarin Pharmaceutical (Subject)
Burkhart Erin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/10/2024
12:14 PM | BioMarin Pharmaceutical (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
07/01/2024
3:19 PM | BioMarin Pharmaceutical (Issuer)
Mueller Brian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
6:28 PM | BioMarin Pharmaceutical (Issuer)
MEIER RICHARD A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
6:29 PM | BioMarin Pharmaceutical (Issuer)
HERON ELAINE J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Think NVDA’s run was epic? You ain’t seen nothin’ yet (Ad) Ask most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade.
In 2023, it surged 239%. And in 2024, it soared another 171% on the year…
But what if I told you there was a way to target those types of “peak Nvidia” profit opportunities in 24 hours or less? Click to find out what Nvidia’s CEO might reveal… and how Sykes is preparing to ride the wave. |
06/04/2024
9:18 AM | Ajer Jeffrey Robert (Reporting)
BioMarin Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/31/2024
5:28 PM | BioMarin Pharmaceutical (Issuer)
Mueller Brian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2024
9:49 AM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/30/2024
5:18 PM | BioMarin Pharmaceutical (Issuer)
Davis George Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2024
1:22 PM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/30/2024
9:10 AM | BioMarin Pharmaceutical (Subject)
LAWLIS V BRYAN (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/30/2024
9:18 AM | BioMarin Pharmaceutical (Subject)
Mueller Brian (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/29/2024
9:28 AM | Ajer Jeffrey Robert (Reporting)
BioMarin Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/28/2024
9:36 AM | BioMarin Pharmaceutical (Subject)
Davis George Eric (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/23/2024
4:23 PM | BioMarin Pharmaceutical (Issuer)
Enyedy Mark J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2024
4:26 PM | BioMarin Pharmaceutical (Issuer)
HERON ELAINE J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2024
4:30 PM | BioMarin Pharmaceutical (Issuer)
Ho Maykin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2024
4:33 PM | BioMarin Pharmaceutical (Issuer)
HOMBACH ROBERT J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2024
4:34 PM | BioMarin Pharmaceutical (Issuer)
MEIER RICHARD A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2024
4:36 PM | BioMarin Pharmaceutical (Issuer)
PYOTT DAVID E I (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2024
4:14 PM | BioMarin Pharmaceutical (Issuer)
Countouriotis Athena (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2024
4:20 PM | BioMarin Pharmaceutical (Issuer)
Dere Willard H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2024
4:06 PM | ANDERSON ELIZABETH M (Reporting)
BioMarin Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2024
4:08 PM | BioMarin Pharmaceutical (Issuer)
Bodem Barbara W. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2024
3:33 PM | BioMarin Pharmaceutical (Issuer)
Hubbard Cristin (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/22/2024
3:36 PM | BioMarin Pharmaceutical (Issuer)
Hubbard Cristin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2024
4:20 PM | BioMarin Pharmaceutical (Issuer)
Burkhart Erin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2024
4:16 PM | BioMarin Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2024
2:57 PM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/10/2024
9:11 AM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/09/2024
9:54 AM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/07/2024
4:58 PM | BioMarin Pharmaceutical (Issuer)
Guyer Charles Greg (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/06/2024
3:40 PM | Ajer Jeffrey Robert (Reporting)
BioMarin Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/06/2024
3:45 PM | BioMarin Pharmaceutical (Issuer)
Davis George Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
